Please login to the form below

Not currently logged in
Email:
Password:

EDCTP

This page shows the latest EDCTP news and features for those working in and with pharma, biotech and healthcare.

EU boost for GSK's Ebola vaccine research

EU boost for GSK's Ebola vaccine research

1.8. The Commission has also asked the European and Developing Countries Clinical Trials Partnership (EDCTP) to include emerging epidemics of concern to Africa, including Ebola, in its work plan. ... This will allow EDCTP, which has been running since

Latest news

  • Europe extends clinical trial project with African researchers Europe extends clinical trial project with African researchers

    The European &Developing Countries Clinical Trials Partnership (EDCTP) was first set up in 2003 and focuses on phase I to IV research into diseases such as HIV/AIDS, tuberculosis and malaria, ... Granting full membership of EDCTP to African countries

  • Europe builds links with African researchers Europe builds links with African researchers

    EDCTP and EFPIA launch fellowship scheme for Africans to spend time at European pharma firms. ... The European &Developing Countries Clinical Trials Partnership (EDCTP) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) are

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Interview: Charles Mgone, EDCTP Interview: Charles Mgone, EDCTP

    Prof Mgone has been executive director of the European and Developing Countries Clinical Trials Partnership (EDCTP) since February 2007. ... EDCTP offers a more cost-effective and unified means of tackling poverty-related diseases.”.

More from intelligence
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashfield

Ashfield, part of UDG Healthcare plc, is a global leader in commercialisation services for the healthcare industry. We partner with...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics